BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

506 related articles for article (PubMed ID: 25459120)

  • 1. Gene therapy of the central nervous system: general considerations on viral vectors for gene transfer into the brain.
    Serguera C; Bemelmans AP
    Rev Neurol (Paris); 2014 Dec; 170(12):727-38. PubMed ID: 25459120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lentivirus-mediated gene transfer to the central nervous system: therapeutic and research applications.
    Wong LF; Goodhead L; Prat C; Mitrophanous KA; Kingsman SM; Mazarakis ND
    Hum Gene Ther; 2006 Jan; 17(1):1-9. PubMed ID: 16409120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adeno-associated virus vectors and neurological gene therapy.
    Ojala DS; Amara DP; Schaffer DV
    Neuroscientist; 2015 Feb; 21(1):84-98. PubMed ID: 24557878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy and neurodevelopmental disorders.
    Gray SJ
    Neuropharmacology; 2013 May; 68():136-42. PubMed ID: 22750077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposomal and viral vectors for gene therapy of the central nervous system.
    de Lima MC; da Cruz MT; Cardoso AL; Simoes S; de Almeida LP
    Curr Drug Targets CNS Neurol Disord; 2005 Aug; 4(4):453-65. PubMed ID: 16101560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Introduction to Viral Vectors and Other Delivery Methods for Gene Therapy of the Nervous System.
    Manfredsson FP
    Methods Mol Biol; 2016; 1382():3-18. PubMed ID: 26611575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adeno-associated virus vectors as therapeutic and investigational tools in the cardiovascular system.
    Zacchigna S; Zentilin L; Giacca M
    Circ Res; 2014 May; 114(11):1827-46. PubMed ID: 24855205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lentiviral vectors for use in the central nervous system.
    Jakobsson J; Lundberg C
    Mol Ther; 2006 Mar; 13(3):484-93. PubMed ID: 16403676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune responses to adenovirus and adeno-associated vectors used for gene therapy of brain diseases: the role of immunological synapses in understanding the cell biology of neuroimmune interactions.
    Lowenstein PR; Mandel RJ; Xiong WD; Kroeger K; Castro MG
    Curr Gene Ther; 2007 Oct; 7(5):347-60. PubMed ID: 17979681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety profile of recombinant adeno-associated viral vectors: focus on alipogene tiparvovec (Glybera®).
    Salmon F; Grosios K; Petry H
    Expert Rev Clin Pharmacol; 2014 Jan; 7(1):53-65. PubMed ID: 24308784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current development of adeno-associated viral vectors.
    Romano G
    Drug News Perspect; 2005 Jun; 18(5):311-6. PubMed ID: 16193103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adeno-associated viral vectors as agents for gene delivery: application in disorders and trauma of the central nervous system.
    Ruitenberg MJ; Eggers R; Boer GJ; Verhaagen J
    Methods; 2002 Oct; 28(2):182-94. PubMed ID: 12413416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gene therapy: new developments].
    Mohr L; Geissler M
    Praxis (Bern 1994); 2002 Dec; 91(51-52):2227-35. PubMed ID: 12564039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene therapy for the CNS using AAVs: The impact of systemic delivery by AAV9.
    Saraiva J; Nobre RJ; Pereira de Almeida L
    J Control Release; 2016 Nov; 241():94-109. PubMed ID: 27637390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adeno-associated virus and lentivirus pseudotypes for lung-directed gene therapy.
    Wilson JM
    Proc Am Thorac Soc; 2004; 1(4):309-14. PubMed ID: 16113451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical applications involving CNS gene transfer.
    Kantor B; McCown T; Leone P; Gray SJ
    Adv Genet; 2014; 87():71-124. PubMed ID: 25311921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HSV vector-mediated gene delivery to the central nervous system.
    Maguire-Zeiss KA; Bowers WJ; Federoff HJ
    Curr Opin Mol Ther; 2001 Oct; 3(5):482-90. PubMed ID: 11699893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Developments in gene delivery vectors for ocular gene therapy].
    Khabou H; Dalkara D
    Med Sci (Paris); 2015 May; 31(5):529-37. PubMed ID: 26059304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AAV-mediated gene therapy for liver diseases: the prime candidate for clinical application?
    van der Laan LJ; Wang Y; Tilanus HW; Janssen HL; Pan Q
    Expert Opin Biol Ther; 2011 Mar; 11(3):315-27. PubMed ID: 21204741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adeno-associated virus and lentivirus vectors: a refined toolkit for the central nervous system.
    Blessing D; Déglon N
    Curr Opin Virol; 2016 Dec; 21():61-66. PubMed ID: 27559630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.